Connect with us
European Gaming Congress 2024

Artificial Intelligence

Plasma Fractionation Market worth $40.4 billion | MarketsandMarkets

Published

on

plasma-fractionation-market-worth-$40.4-billion-|-marketsandmarkets

CHICAGO, Sept. 5, 2023 /PRNewswire/ — The plasma fractionation industry is poised for remarkable growth in the near future, driven by several factors including advancements in biotechnology, increasing demand for plasma-derived therapies, and the global focus on healthcare infrastructure. As precision medicine gains prominence, the industry is expected to witness a surge in the development of novel plasma-derived products tailored to treat specific medical conditions. Additionally, the ongoing research into rare diseases and the escalating aging population will further fuel demand for plasma-based therapies, creating a robust market. Moreover, the industry’s commitment to innovation, coupled with the potential for streamlined production processes and sustainable sourcing of plasma, is likely to enhance accessibility and affordability, ultimately reshaping the landscape of healthcare and therapeutics in the coming years.
Plasma Fractionation Market in terms of revenue was estimated to be worth $29.0 billion in 2023 and is poised to reach $40.4 billion by 2028, growing at a CAGR of 6.9 % from 2023 to 2028 according to a new report by MarketsandMarkets™. The increasing use of immunoglobulins in a variety of therapeutic fields, as well as the market’s players’ strategic expansion of plasma collection centers and inventories, along with the rising incidence of respiratory diseases like alpha-1-antitrypsin deficiency (AATD) and Chronic obstructive pulmonary disease (COPD), are the main factors driving the market’s expansion.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93798284
Browse in-depth TOC on “Plasma Fractionation Market”380 – Tables46 – Figures331 – Pages
Plasma Fractionation Market Scope:
Report Coverage
Details
Market Revenue in 2023
$29.0 billion
Estimated Value by 2028
$40.4 billion
Growth Rate
Poised to grow at a CAGR of 6.9%
Market Size Available for
2021–2028
Forecast Period
2023–2028
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Product, Application, and End User
Geographies Covered
North America, Europe, Asia Pacific, Latin America (LATAM), and Middle East and Africa (MEA)
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Government strategies increasing regional self-sufficiency
Key Market Drivers
Growing prevalence of respiratory diseases and AATD
 
The immunoglobins segment accounted for the largest share by-product in the plasma fractionation market in 2022.
Based on product, the plasma fractionation market is segmented into protease inhibitors, coagulation factor concentrates, immunoglobulins, albumins, and other products. Immunoglobulins accounted for the largest share of the global plasma fractionation market in 2022. The dominance of this segment is mainly attributed to the rise in the cases of neurological and immunological diseases, the increase in off-label utilization of immunoglobulins, especially IVIg, and the increased usage of these immunoglobulins in the treatment of a variety of diseases and conditions that are linked to humoral immune deficiency or immune system dysfunction, including immune thrombocytopenic purpura, Kawasaki syndrome, Guillain-Barré syndrome, and graft-versus-host diseases after bone marrow transplantation.
The pulmonology segment is expected to grow at the highest CAGR during the forecast period.
Based on application, the plasma fractionation market is segmented into pulmonology, hemato-oncology neurology, immunology, hematology, critical care, rheumatology, and other applications. In 2022, the pulmonology segment is expected to register the highest CAGR during the forecast period. The increasing demand for immunoglobulins to prevent and treat upper and lower respiratory tract infections due to their efficiency is a major factor driving growth in this market segment. Additionally, the use of protease inhibitors such as alpha-1-antitrypsin has also increased substantially over the past few years.
North America was the largest regional market for plasma fractionation market in 2022
The global plasma fractionation market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2022, North America accounted for the largest share of the plasma fractionation market, followed by Europe and the Asia Pacific. The significant market share held by North America is supported by the region’s rising hemophilic population as well as the rising demand for immunoglobulins for conditions like PID, idiopathic thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy (CIDP), allogenic bone marrow transplantation, pediatric HIV, and B-cell chronic lymphocytic leukemia. The market in Asia Pacific, on the other hand, is projected to grow at the greatest CAGR throughout the forecast period. This can be attributed to the expansion of the healthcare sector, the increasing incidence of hemophilia, the increase in the number of organ transplants, the increased emphasis on early diagnosis and prophylactic care, the increased awareness of technologically advanced products, and the rising standards of living in many countries in APAC.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=93798284
Plasma Fractionation Market Dynamics:
Drivers:
Growing use of immunoglobulins in various therapeutic areasRapidly growing geriatric populationGrowing prevalence of respiratory diseases and AATDNew indications for plasma productsRestraints:
High costs and limited reimbursementsMarket disruption caused by recombinant alternativesOpportunities:
Increased risk of communicable diseasesRising prevalence of bleeding disordersChallenges:
Reduced supply of plasma due to low donor turnoutStringent government regulationsKey Market Players:
Key players in the plasma fractionation market include CSL (Australia), Takeda Pharmaceutical company limited (Japan), Grifols, S.A. (Spain), Octapharma AG (Switzerland), Kedrion S.P.A (Italy), LFB (France), ADMA Biologics (US), Sanquin (Netherlands), China Biologic Products Holdings Inc. (China), GC Pharma (Korea), Hualan Bioengineering Co., Ltd. (China), Japan Blood Products Organization (Japan), Emergent BioSolutions (US), Shanghai Raas Blood Products Co., Ltd. (China), Intas Pharmaceuticals Ltd. (India), Bharat Serum Vaccines Limited (India), SK Plasma (Korea), Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China), Kamada (Israel), Centurion Pharma (Istanbul), Prothya Biosolutions (Netherlands), PlasmaGen BioSciences Pvt. Ltd. (India), Virchow Biotech Private Limited (India), Fusion Healthcare (India), and Hemarus Therapeutics Limited (India).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=93798284
Plasma Fractionation Market Advantages:
Life-Saving Therapies: Plasma fractionation plays a pivotal role in the production of life-saving therapies such as immunoglobulins, clotting factors, and albumin, which are essential for treating various medical conditions, including immune disorders, hemophilia, and severe burns.Disease Management: Plasma-derived products provide effective disease management options for patients with rare and complex medical conditions, improving their quality of life and life expectancy.Safety and Purity: Rigorous screening and purification processes ensure that plasma-derived products are safe and devoid of pathogens, reducing the risk of infections and adverse reactions.Customized Treatments: Advances in plasma fractionation enable the development of customized treatments tailored to individual patient needs, contributing to the growth of precision medicine.Global Accessibility: Plasma fractionation facilities exist worldwide, increasing the availability of essential therapies to patients in both developed and developing countries, addressing healthcare disparities.Economic Growth: The plasma fractionation industry generates significant economic benefits by creating jobs, fostering research and development, and contributing to the growth of related industries such as healthcare, biotechnology, and pharmaceuticals.Research and Innovation: Continued investment in plasma fractionation research drives innovation in the field, leading to the discovery of new therapies and improved production processes.Sustainability: Efforts to ensure sustainable plasma sourcing, such as voluntary and compensated plasma donation, promote environmental and ethical practices within the industry.Emergency Preparedness: Plasma-derived products are crucial for emergency preparedness and response, as they are used in the treatment of mass casualties resulting from natural disasters, pandemics, and other crises.Long-Term Viability: The plasma fractionation market’s long-term viability is supported by the increasing prevalence of chronic diseases, an aging population, and the continuous need for specialized therapies, ensuring a stable demand for plasma-derived products.In summary, the plasma fractionation market offers a range of advantages that extend beyond healthcare, positively impacting society, the economy, and healthcare systems globally.
Recent Developments:
In April 2023, CSL (Australia) received Food and Drug Administration (FDA) approval for the 50mL/10gm prefilled syringe for Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid for patients suffering from PI and CIPD.In March 2022, Grifols (Spain) received European approvals for XEMBIFY, a 20% subcutaneous immunoglobulin (SCIG)In January 2022, Permira, a global investment firm, announced that it would be acquiring Kedrion and merging the company with BPL.Related Reports:
Biosimilars Market – Global Forecasts to 2028
Clinical Chemistry Analyzers Market – Global Forecasts to 2028
Point of Care Diagnostics Market – Global Forecasts to 2027
Slide Stainers Market – Global Forecasts to 2027
In Vitro Diagnostics Market – Global Forecasts to 2027
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected] Insight: https://www.marketsandmarkets.com/ResearchInsight/plasma-fractionation-market.aspVisit Our Website: https://www.marketsandmarkets.com/Content Source: https://www.marketsandmarkets.com/PressReleases/plasma-fractionation.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
 
View original content:https://www.prnewswire.co.uk/news-releases/plasma-fractionation-market-worth-40-4-billion–marketsandmarkets-301917618.html

Continue Reading
Advertisement

Artificial Intelligence

Supermicro Introduces New Servers and GPU Accelerated Systems with AMD EPYC™ 9005 Series CPUs and AMD Instinct™ MI325X GPUs for AI Ready Data Centers

Published

on

supermicro-introduces-new-servers-and-gpu-accelerated-systems-with-amd-epyc™-9005-series-cpus-and-amd-instinct™-mi325x-gpus-for-ai-ready-data-centers

New Supermicro Systems Enable Customers to Upgrade and Consolidate Data Centers for AI Workloads
SAN JOSE, Calif., Oct. 10, 2024 /PRNewswire/ — Supermicro, Inc. (NASDAQ: SMCI), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, announces the launch of a new series of servers, GPU-accelerated systems, and storage servers featuring the AMD EPYC™ 9005 Series processors and AMD Instinct™ MI325X GPUs. The new H14 product line represents one of the most extensive server families in the industry, including Supermicro’s Hyper systems, the Twin multi-node servers, and AI inferencing GPU systems, all available with air or liquid cooling options.  The new “Zen5” processor core architecture implements full data path AVX-512 vector instructions for CPU-based AI inference and provides 17% better instructions per cycle (IPC) than the previous 4th generation EPYC processor, enabling more performance per core.

Supermicro’s new H14 family uses the latest 5th Gen AMD EPYC processors which enable up to 192 cores per CPU with up to 500W TDP (thermal design power).  Supermicro has designed new H14 systems including the Hyper and FlexTwin™ systems which can accommodate the higher thermal requirements. The H14 family also includes three systems for AI training and inference workloads supporting up to 10 GPUs which feature the AMD EPYC 9005 Series CPU as the host processor and two which support the AMD Instinct MI325X GPU.
“Supermicro’s H14 servers have 2.44X faster SPECrate®2017_fp_base performance1 using the EPYC 9005 64 core CPU as compared with Supermicro’s H11 systems using the second generation EPYC 7002 Series CPUs,” said Charles Liang, president and CEO, Supermicro. “This significant performance improvement allows customers to make their data centers more power efficient by reducing the total data center footprint by at least two-thirds2 while also adding new AI processing capabilities. The H14 server family provides the highest performance, density, and power efficiency available through Supermicro’s liquid and air-cooling options, wide selection of system designs, and proven Building Block Solutions.”
For more information about the Supermicro H14 family of products, please visit: www.supermicro.com/aplus 
“Supermicro’s ‘Building Block Solutions’ has enabled it to consistently deliver time-to-market solutions powered by AMD across a variety of compelling system designs,” said Forrest Norrod, executive vice president and general manager, Data Center Solutions Group, AMD. “Our collaboration with Supermicro, along with their in-house engineering design and manufacturing capabilities worldwide combined with their rack-scale integration capability for both air and liquid-cooled systems enables customers of any scale to generate time-to-value from AMD EPYC CPUs and Instinct GPUs.”
Supermicro’s H14 server lineup consists of the following product families:
Hyper – Supermicro’s flagship enterprise server supports maximum performance from two EPYC 9005 CPUs with up to the maximum 192 cores per CPU at 500W and up to 9TB memory in 24 DIMM slots.  With either a 1U chassis with up to 12 2.5″ NVMe/SATA bays or a 2U chassis with up to 24 2.5″ NVMe/SATA bays, the Hyper’s advanced cooling design accommodates the highest performance CPUs for use in demanding AI inference, enterprise or cloud workloads.
CloudDC – This versatile system is optimized for use in Cloud Data Centers and features a single EPYC 9005 CPU with up to 12 2.5″ NVMe/SATA drive bays in a 1U chassis. It’s designed using the OCP (Open Compute Platform) DC-MHS specification (Data Center Modular Hardware System) which ensures compatibility with OCP standards.
GrandTwin™ – The GrandTwin is a 4-node compute platform using single EPYC 9005 CPU in a very dense 2U form-factor. This system is often used in multi-server cluster applications such as object storage, virtualization, and HPC applications.
FlexTwin™ – The FlexTwin is a 2U 4-node high-performance high-density compute system with dual EPYC 9005 CPUs per node. The advanced liquid-cooling provides high power efficiency and allows the operation of the highest performance EPYC 9005 CPUs for use in HPC, EDA and other demanding workloads.
5U GPU System – Supermicro’s EPYC CPU-based 5U PCIe GPU system supports up to 10 double-width accelerators for design and visualization applications.
4U GPU System (Liquid Cooled) – This highly dense EPYC CPU-based 8-way accelerators platform supports OAM accelerators in the most compact 4U form-factor using advanced liquid-cooling.  It is designed for high-performance AI and HPC applications.
8U GPU System – This 8-way accelerator system uses the AMD Instinct MI325X GPU along with the EPYC 9005 CPU for large-scale LLM AI training. The 8U chassis allows deployment in any air-cooled data center.
Supermicro H14 products with AMD EPYC CPUs are available for customer testing today through Supermicro’s JumpStart program.
Supermicro will present the new H14 solutions at the AMD Advancing AI Day on October 10, 2024, at the San Francisco Moscone Center.
1SPECrate®2017_fp_base of 485 using the Supermicro A+ Server 2023US-TR4 and two AMD EPYC 7702 64 core CPUs (https://www.spec.org/cpu2017/results/res2020q1/cpu2017-20200204-20866.html retrieved October 2, 2024) compared with SPECrate®2017_fp_base of 1670 using the Supermicro AS-2126HS-TN and two AMD EPYC 9555 64 core CPUs.  Results of the AS-2126HS-TN with the 9555 CPU to be published on www.spec.org/cpu2017/results on October 10, 2024.
2Based on the SPECrate®2017_fp_base comparison in footnote (1), reduction in number of systems using the AS-2126HS-TN with the 9555 CPU vs. 2023US-TR4 with the 7702 CPU is 70.9%.
About Super Micro Computer, Inc. Supermicro (NASDAQ: SMCI) is a global leader in Application-Optimized Total IT Solutions. Founded and operating in San Jose, California, Supermicro is committed to delivering first-to-market innovation for Enterprise, Cloud, AI, and 5G Telco/Edge IT Infrastructure. We are a Total IT Solutions provider with server, AI, storage, IoT, switch systems, software, and support services. Supermicro’s motherboard, power, and chassis design expertise further enables our development and production, enabling next-generation innovation from cloud to edge for our global customers. Our products are designed and manufactured in-house (in the US, Taiwan, and the Netherlands), leveraging global operations for scale and efficiency and optimized to improve TCO and reduce environmental impact (Green Computing). The award-winning portfolio of Server Building Block Solutions® allows customers to optimize for their exact workload and application by selecting from a broad family of systems built from our flexible and reusable building blocks that support a comprehensive set of form factors, processors, memory, GPUs, storage, networking, power, and cooling solutions (air-conditioned, free air cooling or liquid cooling).
Supermicro, Server Building Block Solutions, and We Keep IT Green are trademarks and/or registered trademarks of Super Micro Computer, Inc.
All other brands, names, and trademarks are the property of their respective owners.
AMD, the AMD Arrow logo, AMD Instinct, EPYC, and combinations thereof are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners.
 
 
 
 
 
 
 
 
Photo – https://mma.prnewswire.com/media/2527926/Supermicro_H14_Family.jpgPhoto – https://mma.prnewswire.com/media/2527923/Supermicro_AS_8126GS.jpgPhoto – https://mma.prnewswire.com/media/2527924/Supermicro_AS_1116CS.jpgPhoto – https://mma.prnewswire.com/media/2527925/Supermicro_AS_2116GT.jpgPhoto – https://mma.prnewswire.com/media/2527927/Supermicro_AS_2126HS.jpgPhoto – https://mma.prnewswire.com/media/2527928/Supermicro_AS_5126GS.jpgPhoto – https://mma.prnewswire.com/media/2527929/Supermicro_AS_4125GS.jpgPhoto – https://mma.prnewswire.com/media/2527930/Supermicro_AS_2126FT.jpgLogo – https://mma.prnewswire.com/media/1443241/Supermicro_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/supermicro-introduces-new-servers-and-gpu-accelerated-systems-with-amd-epyc-9005-series-cpus-and-amd-instinct-mi325x-gpus-for-ai-ready-data-centers-302273266.html

Continue Reading

Artificial Intelligence

MSI Launches AMD EPYC™ 9005 Series CPU-Based Server Solutions, Delivering Leadership Performance and Density in Data Centers

Published

on

msi-launches-amd-epyc™-9005-series-cpu-based-server-solutions,-delivering-leadership-performance-and-density-in-data-centers

TAIPEI, Oct. 10, 2024 /PRNewswire/ — MSI, a leading global provider of high-performance server solutions, today introduced its latest AMD EPYC™ 9005 Series CPU-based server boards and platforms, engineered to tackle the most demanding data center workloads with leadership performance and efficiency.

Featuring AMD EPYC 9005 Series processors with up to 192 cores and 384 threads, MSI’s new server platforms deliver breakthrough compute power, unparalleled density, and exceptional energy efficiency, making them ideal for handling AI-enabled, cloud-native, and business-critical workloads in modern data centers.
According to Danny Hsu, General Manager of MSI’s Enterprise Platform Solutions, “Our new AMD EPYC 9005 Series CPU-based platforms are not just about raw performance; they represent a strategic leap forward for data centers looking to maximize operational efficiency while minimizing their environmental footprint. These systems ensure that enterprises can stay ahead of evolving industry demands and adapt quickly to new opportunities.”
“5th Gen AMD EPYC Processors deliver the compute capabilities our customers require for their most demanding AI-enabled data center workloads,” said Ravi Kuppuswamy, senior vice president, Server Business Unit, AMD. “Our highly efficient ‘Zen 5’ cores and innovative chiplet-based architecture allowed us to build an advanced, diversified server CPU portfolio that addresses the rapidly evolving needs of our customers and the modern data center.”
DC-MHS Server Solutions Redefining Flexibility and Scalability for Modern Data Centers
MSI’s DC-MHS server solutions address the evolving needs of today’s data centers. Powered by AMD EPYC 9005 Series processors, the DC-MHS series supports the DC-SCM2 server management module, featuring the Aspeed AST2600 BMC, to significantly enhance server maintainability and operational efficiency, enabling enterprises to deploy high-performance systems with the agility needed to stay competitive in today’s rapidly changing market.
DC-MHS Multi-Node Servers
MSI’s DC-MHS multi-node server platforms house multiple nodes within a single chassis, maximizing space and resource utilization while reducing operational costs, enabling modern data centers to future-proof their infrastructure and enhance operational efficiency. Each platform is powered by a single AMD EPYC 9005 Series processor with up to 500W TDP, supports 12 DDR5 DIMM slots for high memory bandwidth, and an OCP NIC for enhanced connectivity.
CD370-S4051-X2 3U 2-Node Core Compute Server: Supports 12 PCIe 5.0 x4 U.2 NVMe bays per node, delivering high-speed I/O and fast data transfer, and is ideal for AI-enabled and data-intensive workloads.CD270-S4051-X2 2U 2-Node Core Compute Server: Equipped with 6 PCIe 5.0 x4 U.2 NVMe bays per node, delivering fast, scalable compute performance, ideal for virtualization and data analytics.CD270-S4051-X4 2U 4-Node Core Compute Server: Features 3 PCIe 5.0 x4 U.2 NVMe bays per node and liquid-cooled options, excelling in throughput-heavy applications such as cloud environments.DC-MHS Enterprise Server
CX271-S4056 2U Enterprise Server: Features a single AMD EPYC 9005 Series processor, 24 DDR5 DIMM slots with speeds up to 5200MT/s, 8 or 24 2.5 inch PCIe 5.0 x4 U.2 NVMe bays, and PCIe 5.0 x16 OCP NIC slots, it delivers fast, scalable performance. Its flexible design, including GPU acceleration options, makes it ideal for data-intensive workloads such as AI, virtualization, and cloud-native applications in modern data centers.DC-MHS Server Boards
D4056 DC-MHS M-DNO Type-4 HPM: Supports a single AMD EPYC 9005 processor, 24 DDR5 DIMM slots, 2 NVMe M.2 ports, PCIe 5.0 expansion slots, and OCP 3.0 NIC support, this platform is built for memory-intensive and data-driven applications, offering fast data access.D4051 DC-MHS M-DNO Type-2 HPM: Designed for power efficiency with a single AMD EPYC 9005 processor, 12 DDR5 DIMM slots, 2 NVMe M.2 ports, and PCIe 5.0 x16 OCP NIC slot, this board delivers scalable performance for latency-sensitive workloads in a half-width form factor.CXL Memory Expansion Server with 8TB Memory for Data-Intensive Workloads
S2301 2U CXL Memory Expansion Server: Powered by dual AMD EPYC 9005 Series processors and 24 DDR5 DIMM slots, the server is engineered to meet the demands of data centers requiring unparalleled memory capacity and scalability. Leveraging advanced CXL 2.0 technology, the S2301 integrates 8 E3.S 2T drive bays for CXL memory and 8 E3.S 1T NVMe storage, expanding total memory capacity to a remarkable 8TB, making it the ideal solution for data-intensive applications, such as In-Memory Database, Electronic Design Automation (EDA), and High-Performance Computing (HPC).
GPU Servers with 4GPU for AI and High-Performance Computing
The G4101-01 and G4101-03 GPU Servers offer exceptional performance for AI, machine learning, and HPC. Powered by a single AMD EPYC 9005 Series processor with 500W TDP and liquid cooling, these servers feature 12 DDR5 DIMM slots and 4 PCIe 5.0 triple-wide slots supporting GPGPUs up to 450W. With 12 PCIe 4.0 U.2 NVMe drives and Platinum or Titanium redundant 3000W power supplies, they deliver the reliability and power required for the most demanding workloads.
Enterprise Servers for Performance-Critical Workloads and Storage Servers for Smaller Data Centers
MSI’s Enterprise and Storage Server lineup now features support for AMD EPYC 9005 Series processors, offering up to 24 DDR5 DIMM slots and delivering exceptional scalability, performance, and memory bandwidth of up to 6000MT/s.
Enterprise Servers S2206-05-10G, S2206-06-10G, and S1206-02-10G are optimized for high-speed data transfer. These models feature 10G SFP+ Ethernet and are tailored for performance-critical workloads such as AI and machine learning. The S2206-06-10G stands out as the highest-performance model in this lineup, designed for data-heavy tasks requiring maximum I/O throughput. It features 3 PCIe 5.0 x16 FHHL slots and 16 PCIe 4.0 U.2 NVMe drives, combined with 8 SATA/SAS bays to deliver exceptional storage capacity and speed. For environments where 1 Gbps network speed is sufficient, Storage Servers such as the S2206-04 offer cost-effective solutions with strong compute and storage performance at a cost-effective price point, making them ideal for smaller data centers.
Supporting Resources:
Watch this video to discover how MSI’s 5th Gen AMD EPYC processor-based servers are redefining data centers for next-generation computing.
Photo – https://mma.prnewswire.com/media/2525385/MSI_DC_MHS_Server_Solutions_Powered_by_AMD_EPYC_9005_Series_Processors_Meet_the_Evolving_Demands_of.jpg

View original content:https://www.prnewswire.co.uk/news-releases/msi-launches-amd-epyc-9005-series-cpu-based-server-solutions-delivering-leadership-performance-and-density-in-data-centers-302270005.html

Continue Reading

Artificial Intelligence

Delegation of International Communication Experts and Foreign Media Outlets Visits Emerging Industry Enterprises in Zhongshan, Guangdong Province

Published

on

delegation-of-international-communication-experts-and-foreign-media-outlets-visits-emerging-industry-enterprises-in-zhongshan,-guangdong-province

BEIJING, Oct. 10, 2024 /PRNewswire/ — On October 9, 2024, the delegation of international communication experts and foreign media outlets, themed “The World Comes to Zhongshan” and organized by the CICG Academy of Translation and Interpretation, visited several representative enterprises in Zhongshan’s emerging industries to experience the development of these innovative sectors.

At the Sinoscience Fullcryo (Zhongshan) Equipment Manufacturing Co. Ltd., delegation members learned about a large hydrogen liquefier capable of producing five tons of liquefied hydrogen per day. This facility was jointly developed, designed, and manufactured by the company and the Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences, achieving the domestic production of large hydrogen liquefiers, with overall performance reaching international advanced levels. Zhongshan has prioritized the hydrogen energy industry and has nurtured several leading enterprises and research institutes in low-temperature technology, thus forming a relatively complete hydrogen energy industrial chain.
At the Zhongshan Institute for Drug Discovery, the delegation received insights into several groundbreaking drugs developed by the institute that are pioneering in both China and globally. The institute is currently working on more than 60 new drugs, with seven of them undergoing clinical trials. This initiative reflects Zhongshan’s commitment to creating a national-level comprehensive platform that integrates biopharmaceutical research and development, technological breakthroughs, platform services, and industrial incubation, all aimed at promoting high-quality development in the biopharmaceutical and health industries within the Greater Bay Area.
During last year’s Hangzhou Asian Games, tens of thousands of spectators benefited from seamless video streaming and video calls through a robust 5G network, supported by Tongyu Communication Co. Ltd., based in Zhongshan. The delegation learned that as China’s pioneering manufacturer of base station antennas, the company has established two overseas production bases in India and Thailand, along with six international branches. Its base station antennas are extensively utilized in over 60 countries and regions and have earned certification as a global supplier from leading telecom equipment manufacturers such as Huawei, ZTE, and Ericsson.
At FCourier, a company specializing in the research, development, operation, and management of high-performance Unmanned Aerial Vehicles (UAVs), flight control systems, and artificial intelligence products, the delegation observed the test flights of two types of UAVs up close. Known for their exceptional performance, the company’s electric vertical take-off and landing fixed-wing UAVs with retractable rotors are sold in multiple Middle Eastern countries. They are effectively applied in various fields, including emergency firefighting, public safety, and energy inspection, and serve as an example of China’s high-end manufacturing going global. Zhongshan aims to gather over 300 relevant enterprises in the industrial chain, achieving an industrial scale exceeding 10 billion yuan, and is committed to establishing a distinctive low-altitude manufacturing industry, which is poised to be a key growth driver for the city’s economy.
Contact: Albert Huang Tel.: 008610-68990638E-mail: [email protected] 
Photo – https://mma.prnewswire.com/media/2528027/CICG.jpgLogo – https://mma.prnewswire.com/media/2297590/4961866/CICG_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/delegation-of-international-communication-experts-and-foreign-media-outlets-visits-emerging-industry-enterprises-in-zhongshan-guangdong-province-302273216.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending